Howard Gurney
Clinical Associate Professor
Oncology
The University of Sydney
Australia
Biography
Howard Gurney is the Director of Medical Oncology and Clinical Research at Macquarie University Hospital. He is a Clinical Associate Professor at both Macquarie University and University of Sydney. He also is a medical oncologist at Westmead Hospital. Professor Gurney has a firm background in clinical research and has subspecialty interests in lymphoma and uro-genital cancers including prostate, bladder, testis and kidney cancer. He has been principle investigator for over 150 phase 2 and 3 clinical studies. He is regarded as a world authority on mechanisms for safe dosing of anticancer agents and has written a number of invited editorials on this topic for the Lancet Oncology and the Journal of Clinical Oncology.
Research Interest
Current research interests include the pharmacogenomics and therapeutic monitoring of chemotherapy and targeted therapies and he has published widely in this area.
Publications
-
Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer.
-
Kinase inhibitor pharmacokinetics: Comprehensive summary and roadmap for addressing inter-individual variability in exposure.
-
e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer.
